Suppliers / Turtle Pharma

Turtle Pharma

India 9 employees Updated 9 July 2026

Turtle Pharma is an API manufacturer based in India. It holds 6 active US drug master files across a filed portfolio of 4 molecules. Customs aggregates show $3K of exports covering 6 molecules to 4 destinations in 2025.

6
active US DMFs
0
valid CEPs
0
registered plants
0
filings across 0 regulators

What they file, and where

Molecule Regulators Docs
Ciprofloxacin US FDA 3
Enrofloxacin US FDA 1
Levofloxacin US FDA 1
Ofloxacin US FDA 1

Also appears on these molecule pages

Scale

Year Revenue Exports Destinations
2025 Not reported $3K 4
2022 Not reported $103K 1

Export figures are customs aggregates. We do not publish the identity of any buyer.

Questions about Turtle Pharma

Does Turtle Pharma hold a US DMF or a CEP?
Turtle Pharma holds 6 active US drug master files. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
What does Turtle Pharma make?
4 molecules are on record against Turtle Pharma, including Ciprofloxacin, Enrofloxacin, Levofloxacin and Ofloxacin. Each links through to that molecule's full manufacturer list.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Turtle Pharma comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
Customs aggregates
Export values, molecule and destination counts